GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pro-Dex Inc (NAS:PDEX) » Definitions » Earnings per Share (Diluted)

Pro-Dex (Pro-Dex) Earnings per Share (Diluted) : $0.58 (TTM As of Mar. 2024)


View and export this data going back to 1986. Start your Free Trial

What is Pro-Dex Earnings per Share (Diluted)?

Pro-Dex's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $0.19. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.58.

Pro-Dex's EPS (Basic) for the three months ended in Mar. 2024 was $0.19. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.58.

Pro-Dex's EPS without NRI for the three months ended in Mar. 2024 was $0.43. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $1.26.

During the past 12 months, Pro-Dex's average EPS without NRIGrowth Rate was 41.10% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -8.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 11.50% per year.

During the past 13 years, Pro-Dex's highest 3-Year average EPS without NRI Growth Rate was 159.60% per year. The lowest was -64.60% per year. And the median was 11.90% per year.


Pro-Dex Earnings per Share (Diluted) Historical Data

The historical data trend for Pro-Dex's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro-Dex Earnings per Share (Diluted) Chart

Pro-Dex Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.97 1.50 1.57 1.21 1.95

Pro-Dex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.42 -0.17 0.14 0.19

Competitive Comparison of Pro-Dex's Earnings per Share (Diluted)

For the Medical Instruments & Supplies subindustry, Pro-Dex's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro-Dex's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's PE Ratio distribution charts can be found below:

* The bar in red indicates where Pro-Dex's PE Ratio falls into.



Pro-Dex Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Pro-Dex's Earnings Per Share (Diluted) for the fiscal year that ended in Jun. 2023 is calculated as

Diluted Earnings Per Share (A: Jun. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(7.074-0)/3.637
=1.95

Pro-Dex's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (Q: Mar. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(0.655-0)/3.524
=0.19

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Pro-Dex  (NAS:PDEX) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Pro-Dex Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Pro-Dex's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro-Dex (Pro-Dex) Business Description

Traded in Other Exchanges
Address
2361 McGaw Avenue, Irvine, CA, USA, 92614
Pro-Dex Inc is engaged in designing, developing, and manufacturing powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. In addition, the company provides engineering consulting and placement services, as well as quality and regulatory consulting services. Most of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.
Executives
Angelita Rebamontan Domingo director 1431 MADISON ST., TUSTIN CA 92782
Van Kirk Richard Lee Jr director, officer: Chief Executive Officer 34 DEER CREEK, IRVINE CA 92604
Philp Katrina Marie Kramer director 5501 NANTUCKET PL, MINNETONKA MN 55345
Farrell William James Iii director 20200 COTTAGEWOOD RD, DEEPHAVEN MN 55331
Peter O. Haeg 10 percent owner 12701 WHITEWATER DR, SUITE 190, MINNETONKA MN 55343
Alisha Charlton officer: Chief Financial Officer 25541 COMMERCENTRE DRIVE, LAKE FOREST CA 92630
Nicholas John Swenson 10 percent owner 5000 WEST 36TH STREET, SUITE 130, MINNEAPOLIS MN 55416
Raymond E Cabillot director 3033 EXCELSIOR BLVD., STE 560, MINNEAPOLIS MN 55416
David Hovda director
Farnam Street Partners Lp /mn 10 percent owner 3033 EXCELSIOR BOULEVARD, MINNEAPOLIS, MINNEAPOLIS MN 55416
Ao Partners I, Lp 10 percent owner 5000 WEST 36TH STREET, SUITE 130, MINNEAPOLIS MN 55416
David Holder director 1052 CHARWOOD LANE, SANTA ANA CA 92705
William L Healey director 101 BULLITT LANE, STE 450, LOUISVILLE KY 40222
Michael J Berthelot director P O BOX 7277, RANCHO SANTA FE CA 92067
George J Isaac director 36 WHISPER DRIVE, WORCESTER MA 01609